Table 2.
5-year relative survival by race, tumor histology, and tumor location in males and females in the NCI Surveillance, Epidemiology and End Results Registry, 1992–2005
| Males |
Females |
|||
|---|---|---|---|---|
| N (%) | 5-year relative survival (95 % CI) | N | 5-year relative survival (95 % CI) | |
| All | 292 (100) | 88.9 % (84.6, 92.1) | 79 (100) | 74.7 % (63.5, 82.9) |
| Racea | ||||
| White | 212 (73) | 90.8 % (85.8, 94.1) | 49 (62) | 73.5 % (58.7, 83.7) |
| Black | 19 (7) | 84.7 % (58.5, 95.0) | 7 (9) | 71.5 % (25.8, 92.1) |
| Asian/Pacific Islander | 58 (20) | 82.9 % (70.4, 90.5) | 23 (29) | 77.9 % (54.6, 90.2) |
| Tumor histology | ||||
| Germinoma | 228 (78) | 91.9 % (87.3, 94.9) | 53 (67) | 84.9 % (71.9, 92.2) |
| Teratoma | 23 (8) | 82.8 % (60.1, 93.3) | 13 (16) | 38.5 % (14.1, 62.9) |
| Other | 41 (14) | 75.7 % (59.5, 86.2) | 13 (16) | 69.3 % (37.3, 87.2) |
| Tumor location | ||||
| Pineal gland | 172 (59) | 91.0 % (85.4, 94.5) | 9 (11) | 88.9 % (43.2, 98.4) |
| Other | 120 (41) | 85.9 % (78.1, 91.1) | 70 (89) | 72.9 % (60.7, 81.8) |
| Radiation therapy | ||||
| Yes | 233 (80) | 90.4 % (85.7, 93.6) | 50 (63) | 90.1 % (77.6, 95.8) |
| No | 56 (19) | 82.0 % (68.9, 90.0) | 26 (33) | 46.3 % (26.7, 63.8) |
| Unknown | 3 (1) | 100% | 3 (4) | 66.7 % (5.4, 94.5) |
a
Does not sum to total because rates were not present for American Indian/Alaskan Natives due to small numbers (N = 3)